Medtech Insights

Despite a changing and challenging reimbursement landscape, the US market for orthotic devices will continue to grow at a modest rate through 2027, primarily driven by favorable demographics,…

Japan’s aging population will drive steady growth in TEO procedure volumes through 2028, supporting TEO device market expansion, although revenue growth will continue to be hindered by the delayed…

The Latin American market for aortic repair devices will expand at a moderate rate, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent…

The US foot and ankle orthopedic device market will be driven by sustained growth in high-volume segments such as fracture fixations, deformity corrections for bunions and hammertoes, and ligament…

Biopsy procedure volumes will continue to grow at a modest rate through 2028, driven by favorable demographic trends, the development of more accurate testing methods, improved imaging technologies…

The global market for hypertension management devices consists of devices that represent a novel form of treatment for patients with uncontrolled hypertension. Given the unmet clinical need for…

The Asia Pacific market for aortic repair devices will expand at a moderate rate, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent…

The European neurovascular device market will grow strongly through 2027, fueled by rapid expansion of the neurovascular thrombectomy device market and by the uptake of newer neurovascular…

The Asia Pacific drug delivery device market will see moderate growth over the forecast period, fueled by the increasing availability of lower-cost generic drug delivery devices and the…

The European drug delivery device market will see modest growth through 2027. Although the increasing availability of biosimilars will negatively impact ASPs, the greater affordability of lower-…

The Asia Pacific dialysis access treatment device market will grow modestly through 2027, driven by rising incidence of ESRD due to the aging population coupled with government initiatives to…

The European market for EP mapping and ablation devices will experience moderate growth through 2027, largely as a result of increasing ablation volumes and the use of premium-priced devices in …